Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Food Industry News Can lab-grown meat scale beyond novelty into global food systems? Discover why lab-grown meat remains scarce nearly a year after approval and whether it can scale to feed the world – read our comprehensive analysis! byPallavi MadhirajuSeptember 19, 2025